ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

ROLF MEINHOLD MD

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,359Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 15

$640K Total Retail Price of All Prescriptions

Rank: 3 out of 15

512 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 512 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 8,378 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 425 378 1 1
LEVOTHYROXINE SODIUM 378 351 2 3
AMLODIPINE BESYLATE 326 308 3 4
LISINOPRIL 289 274 4 5
ATORVASTATIN CALCIUM 279 270 5 10
OMEPRAZOLE 273 236 6 6
CRESTOR 250 241 7 25
SYNTHROID 147 147 8 31
PANTOPRAZOLE SODIUM 137 122 9 44
ZOLPIDEM TARTRATE 135 110 10 13
PRAVASTATIN SODIUM 132 108 11 8
FENOFIBRATE 131 128 12 28
METOPROLOL SUCCINATE 129 100 13 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 125 112 14 16
MELOXICAM 119 101 15 33
LOSARTAN POTASSIUM 117 113 16 15
ATENOLOL 110 88 17 18
METFORMIN HCL ER 103 98 18 37
CITALOPRAM HBR 101 63 19 23
TRAZODONE HCL 100 90 20 35
GLIMEPIRIDE 97 88 21 32
HYDROCODONE-ACETAMINOPHEN 97 71 S3 21 2
CYMBALTA 95 95 23 40
METFORMIN HCL 92 77 24 9
NEXIUM 90 51 25 30
PAROXETINE HCL 88 80 26 45
FLUTICASONE PROPIONATE 85 65 27 39
DIOVAN 81 81 28 55
SERTRALINE HCL 79 78 29 21
TRAMADOL HCL 78 63 30 19
FUROSEMIDE 78 71 30 7
CARVEDILOL 78 71 30 36
METOPROLOL TARTRATE 77 73 33 12
DIOVAN HCT 76 76 34 74
FLUOXETINE HCL 76 71 34 48
BYSTOLIC 76 67 34 95
LOSARTAN-HYDROCHLOROTHIAZIDE 73 55 37 43
LOVASTATIN 73 73 37 22
DONEPEZIL HCL 73 73 37 26
ZETIA 73 69 37 71
GABAPENTIN 71 71 41 14
BUPROPION XL 71 65 41 101
NIASPAN 69 62 43 103
ALLOPURINOL 67 59 44 27
HYDROCHLOROTHIAZIDE 59 58 45 11
NAMENDA 59 59 45 38
VYTORIN 55 47 47 118
BENAZEPRIL HCL 54 54 48 49
POTASSIUM CHLORIDE 53 51 49 29
JANUVIA 53 53 49 53
DILTIAZEM ER 52 52 51 120
CELEBREX 51 48 52 127
PROPRANOLOL HCL 50 50 53 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.